Albemarle vs H.B. Fuller
Add, change or remove companies; up to four.
KIRA’s take AI analyst
I put Albemarle and H.B. Fuller side by side, using each one’s latest annual report. Here is what stands out:
- Albemarle is the larger business, with $5.1B of revenue in fiscal 2025 against $3.5B for H.B. Fuller.
- H.B. Fuller grew revenue faster (−2.7%, against −4.4%).
- Albemarle turned more of its sales into free cash flow (13.5% FCF margin, against 3.5%).
- H.B. Fuller earned a higher return on the capital invested in it (6.3%, against −2.4%).
Who comes out ahead
Of the 10 measures where higher (or lower) is clearly better, how many each company leads.
Albemarle
ALB
2/10
5-year growthFCF margin
H.B. Fuller
FUL
7/10
Revenue growthGross marginNet marginReturn on capitalReturn on equityNet debt / EBITDAShare count change
Side by side
Best in the row
| Latest fiscal year | ALB FY25 | FUL FY25 |
|---|---|---|
| Size | ||
| Market cap | $12.7B | $2.7B |
| Revenue | $5.1B | $3.5B |
| Free cash flow | $692M | $121M |
| Net income | −$511M | $152M |
| Growth | ||
| Revenue growth | −4.4% | −2.7% |
| 5-year growth | 10.5% | 4.5% |
| Share count change | 0.1% | −2.3% |
| Profitability | ||
| Gross margin | 13.0% | 31.1% |
| Operating margin | −7.1% | — |
| Net margin | −9.9% | 4.4% |
| FCF margin | 13.5% | 3.5% |
| Return on capital | −2.4% | 6.3% |
| Return on equity | −5.2% | 7.9% |
| Balance sheet | ||
| Net debt | $1.7B | $1.9B |
| Net debt / EBITDA | 5.8x | 3.6x |
| Dividends and buybacks | $191M | $111M |
| Valuation & quality | ||
| P/E | — | 13.7x |
| Piotroski F-score | 7 | 7 |
Ten years
Revenue
Operating margin
Free cash flow
Return on capital
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.